Search Results

1-20 of 534 results for subject:"Medical treatments"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, when he expects the Government's strategy document on alcohol treatment to be published; what the reason for the delay is; and if he will make a statement. - I have been asked to reply.

Asked by

Norman Lamb (Liberal Democrat)

Answering body

Home Office

Type

Written questions

Status

Answered

Date

9 December 2003

Reference

141984; 415 c366-7W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will list, for each of the cancer networks, the current average waiting time for (a) radiotherapy and (b) chemotherapy from the time of consultant referral; and if he will give comparable figures for (i) 2002, (ii) 2001 and (iii) 1997....

Asked by

Vincent Cable (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

117397; 406 c1119-20W;406 c1121-2W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans there are to provide specialist wards, treatments and guidance for teenage patients being treated within the NHS.

Asked by

Ashok Kumar (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

118179; 406 c1134W;406 c1136W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent assessment he has made of research into (a) the causes and (b) the treatment of prostate cancer; and if he will make a statement. - Inc figures and tables.

Asked by

Lord Coaker (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

5 June 2003

For answer on

13 June 2003

Answered on

13 June 2003

Vernon Coaker: To ask the Secretary of State for Health what recent assessment he has made of research into (a) the causes and (b) the treatment of prostate cancer; and if he will make a statement. [117898] Ms Blears: The main Government agency for research into the causes of and treatments of disease is the Medical Research Council (MRC) which receives its funding from the Department of Trade and Industry via the Office of Science and Technology. The MRC has co-funded two prostate cancer collaboratives with the Department of Health and Cancer Research UK (CRUK). The total funding from all partners is approximately £6 million over five years. These are the ICR Prostate Cancer Collaborative, directed by Colin Cooper and the Northern Prostate Cancer Consortium, directed by David Neal. In March 2000, we announced £1 million additional new funding for urgent research studies into prostate cancer as a mark of its concern over this disease. The NHS Plan went further by announcing that the Government would increase by £1 million the resources devoted to prostate cancer for each of the next three years. This means that, quality permitting, Department of Health direct funding for prostate cancer research will be: _________________________________________________________________________________________________. £ 2000-01 1,200,000 2001-02 2,200,000 2002-03 3,200,000 2003-04 4,200,000 _________________________________________________________________________________________________. This is a twenty-fold increase compared with 1999-2000. Funding in previous years was: _________________________________________________________________________________________________. £ 1999-2000 200,000 1996-97 98,000 _________________________________________________________________________________________________. Examples of research the Department is funding are: A review of new and emerging treatments, for example, brachytherapy and cryotherapy for prostate cancer. Prostate Cancer Studentships, funded jointly with the MRC.

Date

13 June 2003

Reference

117898; 406 c1132-3W;406 c1134-5W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what specific healthcare strategies he has set for the detection and treatment of (a) prostate, (b) lung, (c) bowel and (d) testicular cancer in men; and if he will make a statement. - Inc figures.

Asked by

Nicholas Winterton (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

5 June 2003

For answer on

13 June 2003

Answered on

13 June 2003

Sir Nicholas Winterton: To ask the Secretary of State for Health what specific health care strategies he has set for the detection and treatment of (a) prostate, (b) lung, (c) bowel and (d) testicular cancer in men; and if he will make a statement. [118563] Ms Blears: We are taking action in several areas to improve the detection and treatment of prostate, lung, bowel and testicular cancer: The national health service prostate cancer programme sets out the Government's approach to improving prostate cancer services including the publication of the prostate cancer risk management programme in July 2001 and a commitment to introducing a prostate cancer screening programme if, and when, screening and treatment techniques have developed sufficiently. There has been targeted investment in lung cancer services. An additional £10 million was made available from 1999 to improve lung cancer services. This money is being used to help improve access to services, enhance the quality of treatment and to bring down waiting times for treatment for lung cancer. From 2002-03, this money was placed in baseline allocations. The national cancer director launched the NHS bowel cancer programme on 4 February 2003. This programme will translate into action the Government's commitment to continue to improve services for bowel cancer patients and to introduce a national screening programme for bowel cancer. There are already specialist NHS services for the management of men with testicular cancer and outcomes are generally good with the vast majority of patients being cured. Men should be aware of any unusual changes in their testicles and consult doctors early in order to ensure the maximum chance of a cure. That is why we have collaborated with Cancer Research UK in the production of a testicular self-awareness leaflet "Testicular Cancer: Spot The Symptoms Early", which is widely available. The National Institute for Clinical Excellence (NICE) has published guidance on the use of new generation chemotherapy drugs benefiting around 5,000 lung cancer patients and 7,000 bowel cancer patients each year. NICE is currently preparing guidance on the use of a new drug, Iressa, for the treatment of lung cancer. Last year, NICE published "Improving Outcomes Guidance" (IOG) on the organisation and delivery of services for people with urological cancers, including prostate and testicular cancer. Local NHS organisations are currently developing action plans for implementing the guidance. NICE is currently updating the 1997 IOG for bowel cancer services. The updated guidance is due to be published later this summer. IOG for lung cancer services was published in 1998. NICE is now developing clinical guidelines for the diagnosis and management of lung cancer, which are due to be published in March 2004. We are determined to improve cancer services for all patients, including those with prostate, lung, bowel and testicular cancers. That is why the Cancer Plan is being backed by the biggest ever increase in funding for cancer services. Compared to 2000-01, there will be an additional £570 million a year in 2003-04.

Date

13 June 2003

Reference

118563; 406 c1121W;406 c1123W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many NHS patients have received a drug eluting stent since April 2002. - No figures.

Asked by

Desmond Turner (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

118051; 406 c1130W;406 c1132W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many NHS patients have received an implantable cardioverter defibrillator since April 2002. - Inc figures.

Asked by

Desmond Turner (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

118052; 406 c1130W;406 c1132W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what measures are being taken to assess the extent to which NICE's recommendations on implantable cardioverter defibrillators have been implemented.

Asked by

Lord Beamish (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

118523; 406 c1123W;406 c1125W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what steps his Department is taking to increase the accessibility of health advice and treatment for men. - (Holding answer 12 June 2003).

Asked by

Jim Cunningham (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

5 June 2003

For answer on

13 June 2003

Answered on

13 June 2003

Mr. Jim Cunningham: To ask the Secretary of State for Health what steps his Department is taking to increase the accessibility of health advice and treatment for men. [118495] Ms Blears: [holding answer 12 June 2003]: It is important that men are encouraged to take their health needs seriously and to make full use of the information and treatment services offered by the national health service. Men can benefit from the advice and access to treatment that is available to the whole population. The Department, however, is seeking to make health advice and treatment available to address men's specific needs through a variety of means including the effective use of modern technologies, innovative approaches and more flexible services. Telephone helplines and websites are playing an increasing role in providing information and advice to men. New services such as NHS walk in centres have contributed to improvements in the accessibility of advice and treatment for men. We run promotion campaigns, such as the Sex Lottery, which raises awareness of sexually transmitted diseases and includes material that targets young men in particular. We also work in collaboration with other organisations such as Cancer Research UK with whom we have produced a self awareness leaflet on testicular cancer. The Department works closely with Men's Health Forum, the leading organisation in this field, which has an active information and publications service. We are currently helping to fund the core activities of the Forum and we also fund it to undertake specific projects on men's health. For the future we are undertaking research to inform policy development on access to advice and treatment for men.

Date

13 June 2003

Reference

118495; 406 c1130W;406 c1132W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, whether (a) ooplasmic transfer and (b) oocyte nucleus transfer have been licensed in the United Kingdom by the Human Fertilisation and Embryology Authority.

Asked by

Jim Dobbin (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

117168; 406 c1132W;406 c1134W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many cancer care spell delays were recorded in (a) England, (b) each NHS region and (c) each strategic health authority in each of the last six years; how he defines a cancer care spell delay. - Inc figure.

Asked by

Evan Harris (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

406 c1123W;406 c1125W; 116942;116943

House

House of Commons

Adjournment debate on cancer screening

Adjournment debate on cancer screening.

Lead member

Vincent Cable

Answering member

Hazel Blears

Department

Department of Health

Type

Adjournment debates

Date

13 June 2003

Reference

406 c999-1006

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many teenagers with cancer are being treated on wards intended for use by, or classified as (a) children and (b) old people (i) in England, (ii) within each health authority and (iii) within each hospital in the Middlesbrough South and East...

Asked by

Ashok Kumar (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

13 June 2003

Reference

118178; 406 c1120W;406 c1122W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what recent assessment he has made of the use and abuse of alcohol in other EU countries with special reference to (a) binge drinking and (b) young people; what recent research he has commissioned into the treatment of alcohol abusers in the...

Asked by

Jim Cunningham (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

10 June 2003

Reference

406 c828-9W; 117823;118608;118609

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the (a) efficacy and (b) availability within the NHS of oxaliplatin.

Asked by

Nick Gibb (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

10 June 2003

Reference

117166; 406 c842W;406 c842-3W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what his policy is on the regular use of aspirin to tackle heart disease; and if he will make a statement.

Asked by

Eric Martlew (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 June 2003

Reference

115732; 406 c487W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the recent National Institute for Clinical Excellence reviews of schizophrenia and electro-convulsive therapy; and what impact the recommendations contained will have on policy towards mental health.

Asked by

David Drew (Labour; Co-operative Party)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 June 2003

Reference

115138; 406 c497-8W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how much the National Health Service plans to invest in research into the benefits of alternatives to medication in the treatment of mental ill health in the next five years.

Asked by

Baroness McIntosh of Pickering (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

4 June 2003

Reference

115377; 406 c498W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what relative priority his Department has placed on (a) treatment and (b) research into treatment for cancer patients whose condition has been caused by exposure to asbestos; what estimate he has made of the number of people in the UK likely to...

Asked by

John Robertson (Labour)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 June 2003

Reference

406 c61-2W; 114828;114833;114830;114829

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many patients waited more than (a) 12 and (b) 18 months for cancer treatment in the most recent year for which figures are available. - No figures given.

Asked by

Lord Grayling (Conservative)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

3 June 2003

Reference

111767; 406 c356-7W

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher